NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/04/2025
Voltar para busca
Dado oficial do USPTO
T
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
23
Atualização mais recente
03/05/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 31, 42, 44
Data de depósito
05/06/2024
Data de registro
29/04/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/04/2025
Última transação
03/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
99
Localização do titular
Cambridge, GB
Examinador
CARROLL, DORITT
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of a design in the shape of a light blue puzzle piece surrounding a white letter "T".
Titulares e representantes
Titulares
T-Therapeutics Limited
Representantes
Stacy J. Grossman Law Office of Stacy J. Grossman PLLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 31Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment ofprotection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; chemical and biological pharmaceutical preparations for medical purposes for the treatment ofprotection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; biological preparations for the treatment of cancer; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use namelyfor the treatment ofprotection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; immunotherapeutic drugs namelyfor the treatment ofprotection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; reagents for medical use; diagnostic preparations for medical purposes; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes; living cells for medical use; biological preparations for use in cell cultures for medical purposesnamely for T-cell therapygene therapy and cell therapy; biological and pharmaceutical preparations in the form of living cells for medical use in the treatment of immunological diseases; T-cell therapy pharmaceutical preparations for the treatment ofprotection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; pharmaceutical preparations in the nature of genetically modified immune cells for the treatment of cancer
Classe 9
Downloadable computer software for use in collectinganalyzing and organizing data in the field of pharmaceuticalsbiopharmaceutical drug development and genome engineering; downloadable computer software for use in collectinganalyzing and organizing data in the field of scientific and pharmaceutical research and development; downloadable software for scientific modelling of pharmaceuticals in the field of scientific and pharmaceutical research and development; downloadable software for pharmaceutical modelling in the field of scientific and pharmaceutical research and development; downloadable software for research and development in the field of antibodies; devices for analyzing genome informationlaboratory devices for detecting genetic sequences; downloadable software for performing gene sequencing research and visualizationscientific analysis of genetic sequences; downloadable software for the managinganalysisvisualization of biological data
Classe 31
Live laboratory micelive transgenic mice
Classe 42
Scientificmedical and technological servicesscientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for the treatment ofprotection from and prevention of infectionscancerdiseaseinflammation and autoimmune diseases; design and development of computer hardware and software; platform as a service (PAAS) featuring computer software platforms for use in database management in the field of pharmaceuticalsbiopharmaceutical drug development and genome engineering; Platform as a service (PAAS) featuring computer software platforms for DNA analysis; Platform as a service (PAAS) featuring computer software platforms for use in DNA sequencing; software as a service (SAAS) services featuring software for analyzing DNA; software as a service (SAAS) services featuring software for use in database management in the field of pharmaceuticalsbiopharmaceutical drug development and genome engineering; Providing temporary use of online non-downloadable software for the managementvisualization and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research purposes; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes; biomedical research services in relation to developing transgenic mice; Biomedical research servicespreparation of biological samples in the nature of living cells for analysis and research purposes; Biological analysisnamely structural and functional analysis of genomes for cell therapy and gene therapy; drug discovery services in the field of cell therapy and gene therapy; pharmaceutical drug development servicesdevelopment of gene based medicines and therapies; pharmaceutical drug development servicesdevelopment of pharmaceutical and medical preparations and medicines in the field of cell therapy and gene therapy; research in the field of gene therapy and cell therapy
Classe 44
Medical services; Medical servicesnamely providing medical diagnostic and prognostic services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNAgeneticsgenetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes; mice breeding services; medical services relating to the removaltreatment and processing of living human cells; medical servicesnamely treatment and preparation of living immune cells for medical use; immune cell therapy medical treatment services; medical testing for diagnostic or treatment purposes in the field of cell therapy and gene therapy; medical analysis for diagnostic and treatment purposes and medical consulting in connection with immunotherapy; DNA analysis services in the field of DNA sequencing for diagnostic and treatment purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
23 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
29/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/03/2025
PUBO
PUBLISHED FOR OPPOSITION
11/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/03/2025
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
18/02/2025
ALIE
ASSIGNED TO LIE
18/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/02/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
13/02/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/02/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
13/02/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/02/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/12/2024
GNRT
NON-FINAL ACTION E-MAILED
18/12/2024
CNRT
NON-FINAL ACTION WRITTEN
18/12/2024
DOCK
ASSIGNED TO EXAMINER
18/12/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
17/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/12/2024
NWAP
NEW APPLICATION ENTERED
05/06/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace T ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.